Bronchitis+1
Not yet recruitingStudy of galvokimig versus placebo to assess safety and effectiveness in adults with moderate‑to‑severe chronic obstructive pulmonary disease with chronic bronchitis
Study of galvokimig versus placebo to assess safety and effectiveness in adults with moderate‑to‑severe chronic obstructive pulmonary disease with chronic bronchitis
- Disease:BronchitisChronic obstructive pulmonary disease
- Substances:Galvokimig
Germany- Participants:18–64 years · 65+ years
- Substances:Galvokimig
- Sponsor:UCB Biopharma











